Search Results - "Yano, Kotaro"

Identification and Preparation of a Novel Chemokine Receptor-Binding Domain in the Cytoplasmic Regulator FROUNT by Sonoda, Akihiro, Yoshinaga, Sosuke, Yunoki, Kaori, Ezaki, Soichiro, Yano, Kotaro, Takeda, Mitsuhiro, Toda, Etsuko, Terashima, Yuya, Matsushima, Kouji, Terasawa, Hiroaki

“…FROUNT is a cytoplasmic protein that binds to the membrane-proximal C-terminal regions (Pro-Cs) of chemokine receptors, CCR2 and CCR5. The FROUNT–chemokine…”
Get full text

Evaluating the Ability of Polyhydroxyalkanoate Synthase Mutants to Produce P(3HB-co-3HA) from Soybean Oil by Tsuge, Takeharu, Yamamoto, Tetsuya, Yano, Kotaro, Abe, Hideki, Doi, Yoshiharu, Taguchi, Seiichi

“…Polyhydroxyalkanoate (PHA) synthase from Pseudomonas sp 61‐3 (PhaC1Ps) is able to synthesize P(3HB‐co‐3HA), consisting of a 3HB unit and medium‐chain‐length…”
Get full text

Biosynthesis of Polyhydroxyalkanoate (PHA) Copolymer from Fructose Using Wild-Type and Laboratory-Evolved PHA Synthases by Tsuge, Takeharu, Yano, Kotaro, Imazu, Shin-ichi, Numata, Keiji, Kikkawa, Yoshihiro, Abe, Hideki, Taguchi, Seiichi, Doi, Yoshiharu

“…Eleven laboratory‐evolved polyhydroxyalkanoate (PHA) synthases which originated from Pseudomonas sp. 61‐3 enzyme (PhaC1Ps), together with the wild‐type enzyme,…”
Get full text

Inhibition of Tumor Necrosis Factor-α–Induced Interleukin-6 Expression by Telmisartan Through Cross-Talk of Peroxisome Proliferator-Activated Receptor-γ With Nuclear Factor κB and CCAAT/Enhancer-Binding Protein-β by Tian, Qingping, Miyazaki, Ryohei, Ichiki, Toshihiro, Imayama, Ikuyo, Inanaga, Keita, Ohtsubo, Hideki, Yano, Kotaro, Takeda, Kotaro, Sunagawa, Kenji

“…Telmisartan, an angiotensin II type 1 receptor antagonist, was reported to be a partial agonist of peroxisome proliferator-activated receptor-γ. Although…”
Get full text

Liver X Receptor Activator Downregulates Angiotensin II Type 1 Receptor Expression Through Dephosphorylation of Sp1 by Imayama, Ikuyo, Ichiki, Toshihiro, Patton, Dan, Inanaga, Keita, Miyazaki, Ryohei, Ohtsubo, Hideki, Tian, Qingping, Yano, Kotaro, Sunagawa, Kenji

“…Atherosclerosis is considered to be a combined disorder of lipid metabolism and chronic inflammation. Recent studies have reported that liver X receptors…”
Get full text

Inhibition of Tumor Necrosis Factor-α-Induced Interleukin-6 Expression by Telmisartan Through Cross-Talk of Peroxisome Proliferator-Activated Receptor-y With Nuclear Factor κB and CCAAT/Enhancer-Binding Protein-β by QINGPING TIAN, MIYAZAKI, Ryohei, ICHIKI, Toshihiro, IMAYAMA, Ikuyo, INANAGA, Keita, OHTSUBO, Hideki, YANO, Kotaro, TAKEDA, Kotaro, SUNAGAWA, Kenji

Get full text

Liver X Receptor Activator Downregulates Angiotensin II Type 1 Receptor Expression Through Dephosphorylation of Spl by IMAYAMA, Ikuyo, ICHIKI, Toshihiro, PATTON, Dan, INANAGA, Keita, MIYAZAKI, Ryohei, OHTSUBO, Hideki, QINGPING TIAN, YANO, Kotaro, SUNAGAWA, Kenji

Get full text

Inhibition of tumor necrosis factor-alpha-induced interleukin-6 expression by telmisartan through cross-talk of peroxisome proliferator-activated receptor-gamma with nuclear factor kappaB and CCAAT/enhancer-binding protein-beta by Tian, Qingping, Miyazaki, Ryohei, Ichiki, Toshihiro, Imayama, Ikuyo, Inanaga, Keita, Ohtsubo, Hideki, Yano, Kotaro, Takeda, Kotaro, Sunagawa, Kenji

“…Telmisartan, an angiotensin II type 1 receptor antagonist, was reported to be a partial agonist of peroxisome proliferator-activated receptor-gamma. Although…”
Get full text